Literature DB >> 29345974

Cognitive Effects of Cancer and Cancer Treatments.

Tim A Ahles1, James C Root1.   

Abstract

As the population of cancer survivors has grown into the millions, there has been increasing emphasis on understanding how the late effects of treatment affect survivors' ability to return to work/school, their capacity to function and live independently, and their overall quality of life. This review focuses on cognitive change associated with cancer and cancer treatments. Research in this area has progressed from a pharmacotoxicology perspective to a view of the cognitive change as a complex interaction of aspects of the treatment, vulnerability factors that increase risk for posttreatment cognitive decline, cancer biology, and the biology of aging. Methodological advances include the development of (a) measurement approaches that assess more fine-grained subcomponents of cognition based on cognitive neuroscience and (b) advanced statistical approaches. Conceptual issues that arise from this multidimensional perspective are described in relation to future directions, understanding of mechanisms, and development of innovative interventions.

Entities:  

Keywords:  aging; biomarkers; cancer; cancer treatment; chemotherapy; cognition; endocrine therapy; genetics; neuroimaging; radiation therapy

Mesh:

Year:  2018        PMID: 29345974      PMCID: PMC9118140          DOI: 10.1146/annurev-clinpsy-050817-084903

Source DB:  PubMed          Journal:  Annu Rev Clin Psychol        ISSN: 1548-5943            Impact factor:   22.098


  153 in total

1.  Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study.

Authors:  Brenna C McDonald; Susan K Conroy; Tim A Ahles; John D West; Andrew J Saykin
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

2.  Cross-cultural differences in categorical memory errors.

Authors:  Aliza J Schwartz; Aysecan Boduroglu; Angela H Gutchess
Journal:  Cogn Sci       Date:  2014-03-14

3.  Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study.

Authors:  Brenna C McDonald; Susan K Conroy; Tim A Ahles; John D West; Andrew J Saykin
Journal:  Breast Cancer Res Treat       Date:  2010-08-06       Impact factor: 4.872

4.  Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.

Authors:  Michiel B de Ruiter; Liesbeth Reneman; Willem Boogerd; Dick J Veltman; Frits S A M van Dam; Aart J Nederveen; Epie Boven; Sanne B Schagen
Journal:  Hum Brain Mapp       Date:  2010-07-28       Impact factor: 5.038

5.  Impact of perceived cognitive impairment in breast cancer survivors.

Authors:  Diane Von Ah; Barbara Habermann; Janet S Carpenter; Brandy L Schneider
Journal:  Eur J Oncol Nurs       Date:  2012-08-14       Impact factor: 2.398

6.  Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study.

Authors:  Janette L Vardy; Haryana M Dhillon; Gregory R Pond; Sean B Rourke; Tsegaye Bekele; Corrinne Renton; Anna Dodd; Haibo Zhang; Philip Beale; Stephen Clarke; Ian F Tannock
Journal:  J Clin Oncol       Date:  2015-11-02       Impact factor: 44.544

7.  Intra-individual variability in women with breast cancer.

Authors:  Lori J Bernstein; Pamela A Catton; Ian F Tannock
Journal:  J Int Neuropsychol Soc       Date:  2014-03-12       Impact factor: 2.892

8.  Cognitive deficits in Korean women treated with chemotherapy for breast cancer.

Authors:  Mi Sook Jung; Bernadine Cimprich
Journal:  Cancer Nurs       Date:  2014 May-Jun       Impact factor: 2.592

Review 9.  Chemotherapy-related cognitive dysfunction: current animal studies and future directions.

Authors:  R Seigers; S B Schagen; O Van Tellingen; J Dietrich
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

10.  Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy.

Authors:  Torricia H Yamada; Natalie L Denburg; Leigh J Beglinger; Susan K Schultz
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

View more
  70 in total

1.  Effects of acupuncture versus cognitive behavioral therapy on cognitive function in cancer survivors with insomnia: A secondary analysis of a randomized clinical trial.

Authors:  Kevin T Liou; James C Root; Sheila N Garland; Jamie Green; Yuelin Li; Q Susan Li; Philip W Kantoff; Tim A Ahles; Jun J Mao
Journal:  Cancer       Date:  2020-04-22       Impact factor: 6.860

Review 2.  Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.

Authors:  M Lange; F Joly; J Vardy; T Ahles; M Dubois; L Tron; G Winocur; M B De Ruiter; H Castel
Journal:  Ann Oncol       Date:  2019-12-01       Impact factor: 32.976

3.  The relationship between diet and cognitive function in adult cancer survivors: a systematic review.

Authors:  Daniel Coro; Amanda Hutchinson; Sophie Dahlenburg; Siobhan Banks; Alison Coates
Journal:  J Cancer Surviv       Date:  2019-08-09       Impact factor: 4.442

Review 4.  Cognitive functioning in thyroid cancer survivors: a systematic review and meta-analysis.

Authors:  Omar Saeed; Lori J Bernstein; Rouhi Fazelzad; Mary Samuels; Lynn A Burmeister; Lehana Thabane; Shereen Ezzat; David P Goldstein; Jennifer Jones; Anna M Sawka
Journal:  J Cancer Surviv       Date:  2019-04-04       Impact factor: 4.442

5.  Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx.

Authors:  Lynne I Wagner; Robert J Gray; Joseph A Sparano; Timothy J Whelan; Sofia F Garcia; Betina Yanez; Amye J Tevaarwerk; Ruth C Carlos; Kathy S Albain; John A Olson; Matthew P Goetz; Kathleen I Pritchard; Daniel F Hayes; Charles E Geyer; E Claire Dees; Worta J McCaskill-Stevens; Lori M Minasian; George W Sledge; David Cella
Journal:  J Clin Oncol       Date:  2020-04-09       Impact factor: 44.544

6.  Pretransplantation Cognitive Dysfunction in Advanced-Age Hematologic Cancers: Predictors and Associated Outcomes.

Authors:  James C Root; Claudine Campbell; Xiomara Rocha-Cadman; Nicole Kasven-Gonzalez; Molly Maloy; Jessica Flynn; Sean M Devlin; Ann A Jakubowski
Journal:  Biol Blood Marrow Transplant       Date:  2020-05-21       Impact factor: 5.742

7.  Understanding the Time Course of Cancer-Associated Cognitive Decline: Does Impairment Precede Diagnosis?

Authors:  Brent J Small; Heather S L Jim
Journal:  J Natl Cancer Inst       Date:  2020-05-01       Impact factor: 13.506

8.  Structured Exercise in Cancer Survivors: Is it Enough for Neural, Mental Health and Well-being?

Authors:  Peter Smoak; Victoria Flores; Nicholas Harman; Jonathon Lisano; Reid Hayward; Laura K Stewart
Journal:  Int J Exerc Sci       Date:  2021-04-01

Review 9.  The role of neuro-immune interactions in cancer-related fatigue: Biobehavioral risk factors and mechanisms.

Authors:  Julienne E Bower
Journal:  Cancer       Date:  2019-01-02       Impact factor: 6.860

10.  Co-occurrence of decrements in physical and cognitive function is common in older oncology patients receiving chemotherapy.

Authors:  Inger Utne; Bruce A Cooper; Christine Ritchie; Melisa Wong; Laura B Dunn; Borghild Loyland; Ellen Karine Grov; Marilyn J Hammer; Steven M Paul; Jon D Levine; Yvette P Conley; Kord M Kober; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2020-08-03       Impact factor: 2.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.